Organization of lipid centers operation in the Russian Federation — new opportunities

QR Code

Organization of lipid centers operation in the Russian Federation — new opportunities

Project of the Russian National Atherosclerosis SocietyIn 2016, Guidelines on the medical care organization to the patients with hereditary atherogenic lipid disorders in the regions of Russia were published, which described and presented the principles of routing patients with hereditary dyslipidem...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Ezhov, O. L. Barbarash, M. I. Voevoda, V. S. Gurevich, N. N. Vezikova, D. I. Sadykova, I. V. Sergienko, V. V. Kashtalap, A. N. Meshkov, D. V. Duplyakov, A. A. Sokolov, S. A. Boytsov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-07-01
Series:	Российский кардиологический журнал
Subjects:	lipid center familial hypercholesterolemia dyslipidemia atherosclerosis prevention
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4489
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01)

Actual issues of lipid centers’ operation in Russian Federation
by: S. Boytsov, et al.
Published: (2021-02-01)

Plant sterols and stanols as dietary factors reducing hypercholesterolemia by inhibiting intestinal cholesterol absorption
by: M. A. Khuchieva, et al.
Published: (2011-12-01)

Implemented models and perspectives of managing lipid metabolism disorders. Concept of rare lipid disease centers
by: A. S. Alieva, et al.
Published: (2021-07-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)
by: M. V. Ezhov, et al.
Published: (2020-03-01)

Possible mechanisms of hypercholesterolemia and clinico-prognostic effects of lipid-lowering therapy in patients with coronary heart disease. (Literature review and original data analysis)
by: A. P. Vasilyev, et al.
Published: (2004-12-01)

Modern ultrasound methods and atherosclerosis assessment in patients with familial hypercholesterolemia
by: A. I. Ershova, et al.
Published: (2011-06-01)

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
by: I. V. Sergienko, et al.
Published: (2023-12-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

APPROACHES TO THE LIPID METABOLISM GENES POLYMORPHYSM ANALYSIS IN SCREENING FOR ATHEROSCLEROSIS RISK FACTORS
by: N. V. Koch, et al.
Published: (2014-10-01)

Possibilities of lipid clinics in identifying patients with familial hypercholesterolemia
by: Z. F. Kim, et al.
Published: (2023-03-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
by: V. V. Kukharchuk, et al.
Published: (2020-06-01)

Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor)
by: V. V. Kashtalap
Published: (2024-10-01)

Clinical role of apolipoproteins A and B
by: G. A. Chumakova, et al.
Published: (2011-12-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region
by: N. Yu. Borovkova, et al.
Published: (2023-11-01)

Familial Hypercholesterolemia in Children. The Current State of the Problem
by: Dinara I. Sadykova, et al.
Published: (2023-07-01)

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report
by: A. M. Moiseeva, et al.
Published: (2024-12-01)

Ultrasound examination of achilles tendons in patients with familial hypercholesterolemia
by: V. V. Genkel, et al.
Published: (2018-09-01)

Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk
by: V. S. Emelyanchik, et al.
Published: (2023-08-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)

AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS)
by: S. A. Urazgildeeva, et al.
Published: (2017-11-01)

IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION
by: I. V. Sergienko, et al.
Published: (2018-03-01)

The role of plant stanols in the primary prevention of hypercholesterolemia in patients with arterial hypertension
by: A. S. Safaryan, et al.
Published: (2019-06-01)

Associations of surfactant protein SP-A and SP-D content with blood lipid parameters in men and women of Novosibirsk
by: K. Yu. Nikolaev, et al.
Published: (2023-10-01)

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP
by: V. P. Mikhin, et al.
Published: (2016-12-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
by: V. P. Mikhin, et al.
Published: (2015-12-01)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders
by: O. L. Barbarash, et al.
Published: (2020-09-01)

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
by: M. A. Kachkovsky, et al.
Published: (2020-12-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015-09-01)

Sarcoidosis as a disease associated with metabolic syndrome
by: I. D. Bespalova, et al.
Published: (2023-10-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology
by: S. Yu. Nikulina, et al.
Published: (2019-11-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)